Andrew C Allen

Title: The Innovations of Andrew C Allen

Introduction

Andrew C Allen is an accomplished inventor based in Exton, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of tropane analogs. His work focuses on creating compounds that have potential therapeutic applications, especially in treating cocaine abuse and neurodegenerative disorders.

Latest Patents

Andrew C Allen holds a patent for a family of 4' and 4',4'-substituted-3.alpha.-(diphenylmethoxy)tropane analogs. This invention provides a unique formula that includes various functional groups, such as hydrogen, alkyl, and arylalkyl. The benztropine analogs developed through this patent exhibit a high affinity for the dopamine transporter and inhibit dopamine uptake without displaying a cocaine-like behavioral profile. This innovation has promising implications for treating cocaine abuse and diagnosing neurodegenerative disorders like Parkinson's disease.

Career Highlights

Andrew C Allen is associated with the United States of America as represented by the Department of Health. His work has been instrumental in advancing the understanding of dopamine transporters and their role in addiction and neurodegeneration. With a patent count of 1 patent, he continues to contribute to the scientific community through his research and innovations.

Collaborations

Andrew has collaborated with notable colleagues, including Amy Hauck Newman and Richard H Kline. Their combined expertise has furthered the development of effective pharmaceutical compositions and methods related to his inventions.

Conclusion

Andrew C Allen's innovative work in the field of tropane analogs showcases his commitment to addressing significant health challenges. His contributions have the potential to impact the treatment of addiction and neurodegenerative diseases positively.